Key facts
- Joylux’s last known valuation is $28.7M (Dec 2024).
- It has raised $22.4M across 4 recorded rounds; the latest was Seed Round ($4.5M) in Sep 2024.
- Notable investors include Impact Assets, Springboard Enterprises, Keiretsu Forum, New York Angels, Reform Ventures — 40 tracked in total.
- Joylux has filed 7 Form Ds with the SEC since 2015, most recently Dec 2024 ($4.5M sold to 79 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 40 names
- ·Watchlist + deal alerts for Joylux
Funding rounds
4 roundsAbout Joylux
Operator of an online wellness platform intended to provide vaginal health devices and menopausal products. The company's products use photobiomodulation technology to help alleviate genitourinary syndrome of menopause, while collecting robust health data, enabling women customers to predict what symptoms they are likely to face as they go through the change to drive better health outcomes for them.
- Industry
- Personal Products
- Sector
- Consumer Products and Services (B2C)
- HQ
- Seattle, WA, United States
- Founded
- 2013
- Employees
- 20
- Website
- joylux.com/
- Ownership
- Privately Held (backing)
Joylux doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Joylux shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Joylux in its N-PORT filings yet. We sweep new filings monthly.